Darier disease
ICD-10 Q82.8 · ICD-11 EC20.2

Disseminated Darier Disease When Prior Systemic Therapy Has Not Controlled Skin Lesions

This protocol addresses patients with disseminated (generalised) Darier disease — widespread, non-localised involvement — whose prior systemic treatment course did not achieve adequate disease control.

Clinical Scenario

Darier disease presenting with widespread, non-localised skin lesions. This pattern carries a greater clinical burden than localised disease. Oral retinoids have been established as the most effective oral therapy for generalised Darier disease.

Prior Treatment — Insufficient Response

This protocol applies when the preceding systemic regimen — which may have included doxycycline, cyclosporine, oral contraceptive pills, or fatty acid supplementation — failed to achieve adequate reduction of itching and improvement of skin lesions or skin fragility.

Next-Step Approach (partial overview)

For resistant or recalcitrant disseminated disease, this protocol considers a range of physical and surgical interventions. These modalities have demonstrated outcomes including complete resolution of lesions in selected patients — the full sequence and selection criteria are in the structured protocol.

Treatment goal: Resolution or marked improvement of the skin lesions.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.25259/IJDVL_963_19

Oral retinoids were the most effective oral therapy and were prescribed in the cases of generalized Darier disease.

For localized and resistant skin lesions, physical therapies including surgical excision, dermabrasion and CO2 laser ablation were the first line choices.

With the use of erbium‑doped yttrium aluminium garnet laser (Er: YAG laser), 2 patients with diffuse pruritic lesions in the upper body showed complete resolution.

View source ↗